U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit

October 27, 2021 |
Govt entity, and patients’ rights group oppose Covid drug patent
In a groundbreaking move, Merck and the Medicines Patent Pool ink a licensing deal for a COVID-19 pill
Related Posts
Access to Medicines

Pharma’s alleged “brea...
PEPFAR Watch

PEPFAR is Rolling the Cloc...
Access to Medicines

Pharma Pricing Secrecy Run...